Cargando…

(1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism

BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other...

Descripción completa

Detalles Bibliográficos
Autores principales: Treeriya, Rujikorn, Ho, Phuc N., Titapun, Attapol, Klanrit, Poramate, Suksawat, Manida, Kulthawatsiri, Thanaporn, Sirirattanakul, Suphasarang, Loilome, Watcharin, Namwat, Nisana, Wangwiwatsin, Arporn, Chamadol, Nittaya, Khuntikeo, Narong, Phetcharaburanin, Jutarop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178365/
https://www.ncbi.nlm.nih.gov/pubmed/37187520
http://dx.doi.org/10.7717/peerj.15386
_version_ 1785040844548472832
author Treeriya, Rujikorn
Ho, Phuc N.
Titapun, Attapol
Klanrit, Poramate
Suksawat, Manida
Kulthawatsiri, Thanaporn
Sirirattanakul, Suphasarang
Loilome, Watcharin
Namwat, Nisana
Wangwiwatsin, Arporn
Chamadol, Nittaya
Khuntikeo, Narong
Phetcharaburanin, Jutarop
author_facet Treeriya, Rujikorn
Ho, Phuc N.
Titapun, Attapol
Klanrit, Poramate
Suksawat, Manida
Kulthawatsiri, Thanaporn
Sirirattanakul, Suphasarang
Loilome, Watcharin
Namwat, Nisana
Wangwiwatsin, Arporn
Chamadol, Nittaya
Khuntikeo, Narong
Phetcharaburanin, Jutarop
author_sort Treeriya, Rujikorn
collection PubMed
description BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other Greater Mekong Subregion (GMS) countries. Insights in fecal metabolic changes associated with PDF and CCA are required for further molecular research related to gut health and potential diagnostic biological marker development. METHODS: In this study, nuclear magnetic resonance (NMR) metabolomics was applied for fecal metabolic phenotyping from 55 fecal water samples across different study groups including normal bile duct, PDF and CCA groups. RESULTS: By using NMR spectroscopy-based metabolomics, fecal metabolic profiles of patients with CCA or PDF and of individuals with normal bile duct have been established with a total of 40 identified metabolites. Further multivariate statistical analysis and hierarchical clustering heat map have demonstrated the PDF- and CCA-specific metabotypes through various altered metabolite groups including amino acids, alcohols, amines, anaerobic glycolytic metabolites, fatty acids, microbial metabolites, sugar, TCA cycle intermediates, tryptophan catabolism substrates, and pyrimidine metabolites. Compared to the normal bile duct group, PDF individuals showed the significantly elevated relative concentrations of fecal ethanol, glycine, tyrosine, and N-acetylglucosamine whereas CCA patients exhibited the remarkable fecal metabolic changes that can be evident through the increased relative concentrations of fecal uracil, succinate, and 5-aminopentanoate. The prominent fecal metabolic alterations between CCA and PDF were displayed by the reduction of relative concentration of methanol observed in CCA. The metabolic alterations associated with PDF and CCA progression have been proposed with the involvement of various metabolic pathways including TCA cycle, ethanol biogenesis, hexamine pathway, methanol biogenesis, pyrimidine metabolism, and lysine metabolism. Among them, ethanol, methanol, and lysine metabolism strongly reflect the association of gut-microbial host metabolic crosstalk in PDF and/or CCA patients. CONCLUSION: The PDF- and CCA-associated metabotypes have been investigated displaying their distinct fecal metabolic patterns compared to that of normal bile duct group. Our study also demonstrated that the perturbation in co-metabolism of host and gut bacteria has been involved from the early step since OV infection to CCA tumorigenesis.
format Online
Article
Text
id pubmed-10178365
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-101783652023-05-13 (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism Treeriya, Rujikorn Ho, Phuc N. Titapun, Attapol Klanrit, Poramate Suksawat, Manida Kulthawatsiri, Thanaporn Sirirattanakul, Suphasarang Loilome, Watcharin Namwat, Nisana Wangwiwatsin, Arporn Chamadol, Nittaya Khuntikeo, Narong Phetcharaburanin, Jutarop PeerJ Biochemistry BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other Greater Mekong Subregion (GMS) countries. Insights in fecal metabolic changes associated with PDF and CCA are required for further molecular research related to gut health and potential diagnostic biological marker development. METHODS: In this study, nuclear magnetic resonance (NMR) metabolomics was applied for fecal metabolic phenotyping from 55 fecal water samples across different study groups including normal bile duct, PDF and CCA groups. RESULTS: By using NMR spectroscopy-based metabolomics, fecal metabolic profiles of patients with CCA or PDF and of individuals with normal bile duct have been established with a total of 40 identified metabolites. Further multivariate statistical analysis and hierarchical clustering heat map have demonstrated the PDF- and CCA-specific metabotypes through various altered metabolite groups including amino acids, alcohols, amines, anaerobic glycolytic metabolites, fatty acids, microbial metabolites, sugar, TCA cycle intermediates, tryptophan catabolism substrates, and pyrimidine metabolites. Compared to the normal bile duct group, PDF individuals showed the significantly elevated relative concentrations of fecal ethanol, glycine, tyrosine, and N-acetylglucosamine whereas CCA patients exhibited the remarkable fecal metabolic changes that can be evident through the increased relative concentrations of fecal uracil, succinate, and 5-aminopentanoate. The prominent fecal metabolic alterations between CCA and PDF were displayed by the reduction of relative concentration of methanol observed in CCA. The metabolic alterations associated with PDF and CCA progression have been proposed with the involvement of various metabolic pathways including TCA cycle, ethanol biogenesis, hexamine pathway, methanol biogenesis, pyrimidine metabolism, and lysine metabolism. Among them, ethanol, methanol, and lysine metabolism strongly reflect the association of gut-microbial host metabolic crosstalk in PDF and/or CCA patients. CONCLUSION: The PDF- and CCA-associated metabotypes have been investigated displaying their distinct fecal metabolic patterns compared to that of normal bile duct group. Our study also demonstrated that the perturbation in co-metabolism of host and gut bacteria has been involved from the early step since OV infection to CCA tumorigenesis. PeerJ Inc. 2023-05-09 /pmc/articles/PMC10178365/ /pubmed/37187520 http://dx.doi.org/10.7717/peerj.15386 Text en © 2023 Treeriya et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biochemistry
Treeriya, Rujikorn
Ho, Phuc N.
Titapun, Attapol
Klanrit, Poramate
Suksawat, Manida
Kulthawatsiri, Thanaporn
Sirirattanakul, Suphasarang
Loilome, Watcharin
Namwat, Nisana
Wangwiwatsin, Arporn
Chamadol, Nittaya
Khuntikeo, Narong
Phetcharaburanin, Jutarop
(1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title_full (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title_fullStr (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title_full_unstemmed (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title_short (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
title_sort (1)h nmr fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178365/
https://www.ncbi.nlm.nih.gov/pubmed/37187520
http://dx.doi.org/10.7717/peerj.15386
work_keys_str_mv AT treeriyarujikorn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT hophucn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT titapunattapol 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT klanritporamate 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT suksawatmanida 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT kulthawatsirithanaporn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT sirirattanakulsuphasarang 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT loilomewatcharin 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT namwatnisana 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT wangwiwatsinarporn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT chamadolnittaya 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT khuntikeonarong 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism
AT phetcharaburaninjutarop 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism